Lectin, Galactoside-Binding, Soluble, 13 Proteine (LGALS13)

Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. Zusätzlich bieten wir Ihnen Lectin, Galactoside-Binding, Soluble, 13 Antikörper (123) und Lectin, Galactoside-Binding, Soluble, 13 Kits (23) und viele weitere Produktgruppen zu diesem Protein an.

alle Proteine anzeigen Gen GeneID UniProt
LGALS13 29124 Q9UHV8
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top Lectin, Galactoside-Binding, Soluble, 13 Proteine auf antikoerper-online.de

Showing 7 out of 9 products:

Katalog Nr. Origin Quelle Konjugat Bilder Menge Lieferzeit Preis Details
Escherichia coli (E. coli) Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg 30 bis 35 Tage
Escherichia coli (E. coli) Human His tag 100 μg 13 bis 16 Tage
HEK-293 Cells Human Myc-DYKDDDDK Tag Validation with Western Blot 20 μg 11 Days
Wheat germ Human GST tag 10 μg 11 bis 12 Tage
Escherichia coli (E. coli) Human His tag,GST tag 100 μg 15 bis 18 Tage
Escherichia coli (E. coli) Human Unkonjugiert   100 μg 2 bis 3 Tage
Human Unkonjugiert   100 μg 6 Days

LGALS13 Proteine nach Spezies und Herkunft

Origin Exprimiert in Konjugat
Human , ,
, , ,

Weitere Proteine zu Lectin, Galactoside-Binding, Soluble, 13 (LGALS13) Interaktionspartnern

Human Lectin, Galactoside-Binding, Soluble, 13 (LGALS13) Interaktionspartner

  1. These results indicate that Gal-13 is not a normal galectin, which could not bind to beta-galactosides. Lastly, the distribution of EGFP-tagged wild-type Gal-13 and its variants in HeLa cells showed that they are concentrated in the nucleus and could be co-localized within filamentary materials, possibly actin.

  2. PP13 is located in and on all types of syncytiotrophoblast extracellular vesicles. A simple correction for gestational age suggested that preeclampsia may be an important influence.

  3. Galectin-13 does not bind beta-galactosides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138.

  4. First-trimester PP-13 levels are significantly correlated with BMI and smoking. These correlations appear independent of uterine and umbilical artery resistance. In low risk patients, PP-13 levels fail to predict the risk for pre-eclampsia or small for gestational age (SGA) neonates.

  5. Gal-3 was significantly downregulated only in the extravillous trophoblast of intrauterine growth restriction ( IUGR) placentas. In contrast, expressions of gal-2 and gal-13 were downregulated in both villous and extravillous trophoblast cells of IUGR placentas.

  6. Placental protein 13 was localized to syncytiotrophoblasts in the chorionic villi and to occasional multinucleated luminal trophoblasts within converted decidual spiral arterioles in preeclampsia patients.

  7. inadequate sensitivity as first trimester serum marker for pre-eclampsia

  8. As gal-13 with its anti-inflammatory functions plays a role in maternal immune system, a lack of gal-13 may contribute to an imbalance in inflammation processes in the placenta during pregnancy and therefore influences development of gestational diabetes.

  9. Evaluation of placental protein 13 (PP13) and risk factors as markers for predicting preeclampsia.

  10. Among singletons with severe preeclampsia, levels were significantly reduced, however, among twins, only a non-significant tendency for a reduction was recorded.

  11. Data in rats suggest that human LGALS13 plays role in maintaining uteroplacental blood flow and plays possible role in facilitating proper adaptation of maternal vasculature to pregnancy.

  12. The maternal serum level of placental protein 13 is significantly lower in Egyptian patients with pre-eclampsia compared to controls.

  13. secretion of PAPP-A, ADAM12 and PP13 is closely related to the size of the placenta in the beginning of pregnancy. After 8 weeks of pregnancy, which is the time for luteoplacental shift, the correlation disappears.

  14. PP13 is released from the syncytiotrophoblast in preterm preeclampsia and HELLP, mimicked in BeWo cells by ischemic stress, suggesting PP13 is a placental alarmin.

  15. ABO blood group can alter PP13-bioavailability in blood

  16. PP13 was best in predicting early onset pre-eclampsia with a sensitivity of 79% at a 20% false positive rate.

  17. PP13 mRNA is lower in the third trimester at the time of disease while protein level accumulates and become higher creating an unparallel change in the level of the mRNA and the corresponding protein.

  18. PP13 levels were decreased in women with preeclampsia.

  19. PP13 is a suitable stable molecule and can be treated under routine laboratory and transport temperatures.

  20. gene polymorphism is associated with an increased risk of preterm labour

Lectin, Galactoside-Binding, Soluble, 13 (LGALS13) Protein Überblick

Protein Überblick

Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family.

Genbezeichner und Symbole assoziert mit LGALS13

  • galectin 13 (LGALS13)
  • avian beta-defensin 13 (AvBD13)
  • Gal-11 Protein
  • gal-13 Protein
  • Gal11 Protein
  • GAL13 Protein
  • PLAC8 Protein
  • PP13 Protein

Bezeichner auf Proteinebene für LGALS13

beta-galactoside-binding lectin , gal-13 , galactoside-binding soluble lectin 13 , galectin 13 , galectin-13 , placental protein 13 , placental tissue protein 13 , Beta-defensin 13 , Gallinacin-11 , beta-defensin 13 , gallinacin-11 , gallinacin-13

29124 Homo sapiens
414877 Gallus gallus
Ausgewählte Anbieter für Lectin, Galactoside-Binding, Soluble, 13 Proteine (LGALS13)
Haben Sie etwas anderes gesucht?